Search results
5 Things to Know: COVID-19 Vaccines for Immunocompromised People
Medscape· 6 days agoCDC experts share what clinicians should know about COVID-19 prevention in immunocompromised...
S&P 500 Gains and Losses Today: Norwegian Cruise Soars on Guidance, Strategy Update
Investopedia· 2 days agoIn the days ahead, quarterly results from semiconductor giant Nvidia (NVDA) could provide a gauge of...
Josh Gottheimer's recent transactions in Adobe, Agree Realty, Alphabet and more By Investing.com
Investing.com· 5 days agoJosh Gottheimer's recent transactions in Adobe, Agree Realty, Alphabet and more
Novavax investor drops proxy battle in wake of big pharma deal - Washington Business Journal
The Business Journals· 2 days agoA Novavax Inc. shareholder that had been waging a campaign to oust three board members has withdrawn...
Temedica Expands Its Advisory Board With Former Gematik CEO Markus Leyck Dieken
NewMediaWire via Yahoo Finance· 6 days agoDr. med. Markus Leyck Dieken, former CEO of Gematik, joins the Advisory Board of Temedica. Dr. Leyck...
Whole Foods Hepatitis; Plane Crash Kills Physician; Docs Criticize Mask Ban Proposal
MedPage Today· 2 days agoADHD drug shortages may finally be easing, but the struggle for patients may not be over. Children...
How the love story between von der Leyen and Pfizer turned sour
Euronews via Yahoo News· 5 days agoFrom making her Europe’s vaccine saviour to becoming a skeleton in her closet: All the ebbs and...
Vaxxinity leaders detail retreat from 'abusive relationship' after 3 years on public market
FierceBiotech· 7 days agoVaxxinity, which filed to delist from the Nasdaq last month, is choosing radical transparency about...
Blocking a Fair WHO Pandemic Accord Endangers Humanity
Foreign Policy Magazine· 2 days agoIn Liu Cixin’s science fiction novel The Dark Forest—part of the popular Three-Body Problem series...
Protecting therapy patients from exploitation
Politico· 2 days agoSTUDY THIS — The implications of the public’s preexisting condition — amnesia. — US race-neutral lung assessments to have profound effects, study finds. — Moderna wins patent case in Europe ...